Twin Tree Management, LP Reata Pharmaceuticals Inc Call Options Transaction History

Twin Tree Management, LP

  • $50 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2021

Feb 10, 2022
SELL
$25.61 - $110.96 $504,517 - $2.19 Million
-19,700 Closed
0 $0
Q2 2021

Aug 12, 2021
BUY
$78.27 - $151.29 $1.54 Million - $2.98 Million
19,700 New
19,700 $2.79 Million
Q2 2020

Aug 12, 2020
SELL
$126.3 - $176.56 $833,580 - $1.17 Million
-6,600 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$74.57 - $217.92 $492,161 - $1.44 Million
6,600 New
6,600 $1.35 Million

Others Institutions Holding RETA

# of Institutions
5
Shares Held
62.7K
Call Options Held
0
Put Options Held
0
View Full List

About REATA PHARMACEUTICALS INC

RETA Quotes by TradingView
  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Twin Tree Management, LP Portfolio

Follow Twin Tree Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Twin Tree Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email